Fibrodyplasia Ossificans Progressiva (FOP)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Fibrodyplasia Ossificans Progressiva (FOP) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

WithdrawnPhase 3

NCT04577820

Study to Assess the Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans Progress…

The primary safety objective of the study is to assess the safety and tolerability of garetosmab in Japanese male and female adult patients with FOP. The prima…

Location not specified0Started 2021-10-13

Treatment: garetosmab